Cytokines and the hepatic acute phase response

Journal of Pathology

Volumn 181, Issue 3, 1997, Pages 257-266

  Moshage, Han ^a,b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

2 macroglobulin; Acute phase proteins; Acute phase response; Cytokines; Extracellular matrix; Growth factors; HGF; Inflammation; Interleukins; Liver fibrosis; Liver regeneration; Signal transduction; TGF

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA 2 MACROGLOBULIN; CYTOKINE; GROWTH FACTOR; TRANSFORMING GROWTH FACTOR;

ACUTE PHASE RESPONSE; EXTRACELLULAR MATRIX; HOMEOSTASIS; HUMAN; HUMAN CELL; LIVER FIBROSIS; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; REVIEW;

ACUTE-PHASE PROTEINS; ACUTE-PHASE REACTION; CYTOKINES; GROWTH SUBSTANCES; HUMANS; INTERLEUKIN-6; LIVER; LIVER CIRRHOSIS; LIVER REGENERATION; RECEPTORS, CYTOKINE; SIGNAL TRANSDUCTION;

EID: 0031006421     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199703)181:3<257::AID-PATH756>3.0.CO;2-U     Document Type: Review

References (114)

1. Kushner I. The phenomenon of the acute phase response. Ann NY Acad Sci 1982; 389: 39-48.
2. Baumann H, Gauldie J, The acute phase response. Immunol Today 1994; 15: 74-80.
3. Koj A. Biological functions of acute-phase proteins. In: Gordon AH, Koj A, eds. The Acute Phase Response to Injury and Infection. Amsterdam: Elsevier, 1985; 145-160.
4. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996; 87: 2095-2147.
5. McMahan CJ, Slack JL, Mosley B, et al. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J 1991; 10: 2821-2832.
6. Oldenburg HSA, Pruitt JH, Lazarus DD, et al. Interleukin 1 binding to its type I, but not type II, receptor modulates the in vivo acute phase response. Cytokine 1995; 7: 510-516.
7. Giri JG, Robb R, Wong WL, Horuk R. HepG2 cells predominantly express the type II interleukin 1 receptor (biochemical and molecular characterization of the IL-1 receptor). Cytokine 1992; 4: 18-23.
8. Gallis B, Prickelt KS, Jackson J, et al. IL-1 induces rapid phosphorylation of the IL-1 receptor. J Immunol 1989; 143: 3235-3240.
9. Bazzoni F, Beutler B. The tumor necrosis factor ligand and receptor families. N Engl J Med 1996; 334: 1717-1725.
10. Vilcek J, Lee TH. Tumor necrosis factor. J Biol Chem 1991; 266: 7313-7316.
11. Heller RA, Krönke M. Tumor necrosis factor receptor-mediated signalling pathways. J Cell Biol 1994; 126: 5-9.
12. Adamson GM, Billings RE. Tumor necrosis factor: receptor binding and expression of receptors in cultured mouse hepatocytes. J Pharmacol Exp Ther 1994; 269: 367-373.
13. Volpes R, van den Oord JJ, de Vos R, Desmet V. Hepatic expression of type A and type B receptors for tumor necrosis factor. J Hepatol 1992; 14: 361-369.
14. Pfeffer K, Matsuyama T, Kündig TM, et al. Mice deficient for the 55 kD tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 1993; 73: 457-467.
15. Leist M, Gantner F, Künstle G, et al. The 55-kD tumor necrosis factor receptor and CD95 independently signal murine hepatocyte apoptosis and subsequent liver failure. Mol Med 1996; 2: 109-124.
16. Mosselmans R, Hepburn A, Dumont JE, Fiers W, Galand P. Endocytic pathway of recombinant murine TNF in L929 cells. J Immunol 1988; 141: 3096-3100.
17. Kishimoto T, Akira S, Narazaki M, Taga T. Interleukin-6 family of cytokines and gp130. Blood 1995; 86: 1243-1254.
18. Liu J, Modrell B, Aruffo A, et al. Interleukin-6 signal transducer gp130 mediates oncostatin M signalling. J Biol Chem 1992; 267: 16763-16766.
19. Thoma B, Bird TA, Friend DJ, Gearing DP, Dower SK. Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes. J Biol Chem 1994; 269: 6215-6222.
20. Sporeno E, Paonessa G, Salvati AL, et al. Oncostatin M binds directly to gp130 and behaves as IL-6 antagonist on a cell line expressing gp130 but lacking functional Oncostatin M receptors. J Biol Chem 1994; 269: 10991-10995.
21. Murakami-Mori T, Taga T, Kishimoto T, Nakamura S. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or IL-6 receptor. J Clin Invest 1995; 96: 1319-1327.
22. Bellido T, Stahl N, Farruggella TJ, Borba V, Yancopoulos GD, Manolagas SC. Detection of receptors for IL-6, IL-11, LIF, oncostatin M and CNTF in bone marrow stromal/osteoblastic cells. J Clin Invest 1996; 97: 431-437.
23. Hilton DJ, Hilton AA, Raicevic A, et al. Cloning of a murine IL-11 receptor α-chain; requirements for gp130 for high affinity binding and signal transduction. EMBO J 1994; 13: 4765-4775.
24. Fourcin M, Chevalier S, Lebrun J-J, et al. Involvement of gp130/IL-6 receptor transducing component in IL-11 receptor. Eur J Immunol 1994; 24: 277-280.
25. Cherel M, Sorel M, Lebeau B, et al. Molecular cloning of two isoforms of a receptor for the human hematopoietic cytokine IL-11. Blood 1995; 86: 2534-2540.
26. Pennica D, Shaw KJ, Swanson TA, et al. Cardiotrophin-1. Biological activities and binding to the LIF receptor/gp130 signalling complex. J Biol Chem 1995; 270: 10915-10922.
27. Kolesnick R, Golde DW. The sphingomyelin pathway in tumor necrosis factor and IL-1 signalling. Cell 1994; 77: 325-328.
28. Kishimoto T, Taga T, Akira S. Cytokine signal transduction. Cell 1994; 76: 253-262.
29. Wegenka UM, Buschmann J, Lütticken C, Heinrich PC, Horn F. Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by IL-6 at the posttranslational level. Mol Cell Biol 1993; 13: 276-288.
30. Darnell JE, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signalling proteins. Science 1994; 264: 1415-1421.
31. Ihle JN. STATs: signal transducers and activators of transcription. Cell 1996; 84: 331-334.
32. Akira S, Nishio Y, Inoue M, et al. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signalling pathway. Cell 1994; 77: 63-71.
33. Zhong Z, Wen Z, Darnell JE. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and IL-6. Science 1994; 264: 95-98.
34. Ripperger J, Fritz S, Richter K. Isolation of two IL-6 response element binding proteins from acute phase rat livers. Ann NY Acad Sci 1995; 762: 252-260.
35. Hilton DJ. LIF: lots of interesting functions. Trends Biochem Sci 1992; 17: 72-77.
36. Hilton DJ, Gough NM. Leukemia inhibitory factor: a biological perspective. J Cell Biochem 1991; 46: 21-26.
37. Baumann H, Wong GG. Hepatocyte-stimulating factor III shares structural and functional identity with LIF. J Immunol 1989; 143: 1163-1167.
38. Kordula T, Rokita H, Koj A, Fiers W, Gauldie J, Baumann H. Effects of IL-6 and LIF on the acute phase response and DNA synthesis in cultured rat hepatocytes. Lymphokine Cytokine Res 1991; 10: 23-26.
39. Baumann H, Won K-A, Jahreis GP. Human hepatocyte-stimulating factor III and IL-6 are structurally and immunologically distinct but regulate the production of the same acute phase plasma proteins. J Biol Chem 1989; 264: 8046-8051.
40. Waring P, Wycherley K, Cary D, Nicola N, Metcalf D. Leukemia inhibitory factor levels are elevated in septic shock and various inflammatory body fluids. J Clin Invest 1992; 90: 2031-2037.
41. Waring PM, Waring LJ, Billington T, Metcalf D, Leukemia inhibitory factor protects against experimental lethal E. coli septic shock in mice. Proc Natl Acad Sci USA 1995; 92: 1337-1341.
42. Alexander HR, Wong GGH, Doherty GM, Venzon DJ, Fraker DL, Norton JA. Differentiation factor/LIF protection against lethal endotoxemia in mice: synergistic effect with IL-1 and tumor necrosis factor. J Exp Med 1992; 175: 1139-1142.
43. Randow F, Syrbe U, Meisel C, et al. Mechanism of endotoxin desensitization: involvement of IL-10 and transforming growth factor ß. J Exp Med 1995; 181: 1887-1892.
44. Metcalf D, Gearing DP. Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor. Proc Natl Acad Sci USA 1989; 86: 5948-5952.
45. Richards CD, Brown TJ, Shoyab M, Baumann H, Gauldie J. Recombinant oncostatin M stimulates the production of acute phase proteins in HepG2 cells and rat primary hepatocytes in vitro. J Immunol 1992; 148: 1731-1736.
46. Baumann H, Schendel P, Interleukin-11 regulates the hepatic expression of the same plasma protein genes as IL-6. J Biol Chem 1991; 266: 20424-20427.
47. Nesbitt JE, Fuentes NL, Fuller GM. Ciliary neurotrophic factor regulates fibrinogen gene expression in hepatocytes by binding to the interleukin-6 receptor. Biochem Biophys Res Commun 1993; 190: 544-550.
48. Schooltink H, Stoyan T, Roeb E, Heinrich PC, Rose-John S, Ciliary neurotrophic factor induces acute phase protein expression in hepatocytes. FEBS Lett 1992; 314: 280-284.
49. Pennica D, King KL, Shaw KJ, et al. Expression cloning of cardiotrophin 1. a cytokine that induces cardiac myocyte hypertrophy. Proc Natl Acad Sci USA 1995; 92: 1142-1146.
50. Richards CD, Langdon C, Pennica D, Gauldie J. Murine cardiotrophin-1 stimulates the acute phase response in rat hepatocytes and H35 hepatoma cells. J Interferon Cytokine Res 1996; 16: 69-75.
51. Peters M, Roeb E, Pennica D, Meyer zum Büschenfelde KH, Rose-John S. A new hepatocyte stimulating factor: cardiotrophin-1 (CT-1). FEBS Lett 1995; 372: 177-180.
52. Kopf M, Baumann H, Freer G, et al. Impaired immune and acute-phase responses in IL-6-deficient mice. Nature 1994; 368: 339-342.
53. Fattori E, Cappelletti M, Costa P, et al. Defective inflammatory response in IL-6-deficient mice. J Exp Med 1994; 180: 1243-1250.
54. Scotte M, Hiron M, Masson S, et al. Differential expression of cytokine genes in monocytes, peritoneal macrophages and liver following endotoxinor turpentine-induced inflammation in rat. Cytokine 1996; 8: 115-120.
55. Arend WP. Interleukin-1 receptor antagonist. J Clin Invest 1991; 88: 1445-1451.
56. Dinarello CA, Thompson RC. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol Today 1991; 12: 404-410.
57. Dripps DJ, Verderber E, Ng RK, Thompson RC, Eisenbers SP. Interleukin-1 receptor antagonist binds to the type II interleukin-1 receptor on B cells and neutrophils. J Biol Chem 1991; 266: 20311-20315.
58. McIntyre KW, Stepan GJ, Kolinsky KD, et al. Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody. J Exp Med 1991; 173: 931-939.
59. Gershenwald JE, Fong Y, Fahey TJ, et al. Interleukin 1 receptor blockade attenuates the host inflammatory response. Proc Natl Acad Sci USA 1990; 87: 4966-1970.
60. Bevan S, Raynes JG. IL-1 receptor antagonist regulation of acute phase protein synthesis in human hepatoma cells. J Immunol 1991; 147: 2574-2578.
61. Gabay C, Genin B, Mentha G, Iynedjian PB, Roux-Lombard P, Guerne P-A. IL-1 receptor antagonist (IL-1Ra) does not inhibit the production of C-reactive protein or serum amyloid A protein by human primary hepatocytes. Differential regulation in normal and tumour cells. Clin Exp Immunol 1995; 100: 306-313.
62. 2-dependent: effects of IL-1 receptor antagonist (IL-1RA). Mol Cell Biochem 1995; 142: 171-178.
63. Steinkasserer A, Estaller C, Weiss EH, Sim RB. Human interleukin-1 receptor antagonist is expressed in liver. FEBS Lett 1992; 310: 60-62.
64. Symons JA, Eastgate JA, Duff GW. Purification and characterization of a novel soluble receptor for interleukin 1. J Exp Med 1991; 174: 1251-1254.
65. Giri JG, Wells J, Dower SK, et al. Elevated levels of shed type II IL-1 receptor in sepsis. J Immunol 1994; 153: 5802-5809.
66. Pruitt JH, Welborn MB, Edwards PD, et al. Increased soluble IL-1 type II receptor concentrations in postoperative patients and in patients with sepsis syndrome. Blood 1996; 87: 3282-3288.
67. Burger D, Chicheportiche R, Giri JG, Dayer JM. The inhibitory activity of human IL-1 receptor antagonist is enhanced by type II IL-1 soluble receptor and hindered by type I IL-1 soluble receptor. J Clin Invest 1995; 96: 38-41.
68. Fisher CJ, Agosti JM, Opal SM, et al. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. N Engl J Med 1996; 334: 1697-1702.
69. Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci USA 1992; 89: 4845-4849.
70. Gabay C, Silacci P, Genin B, Mentha G, Le Coultre C, Guerne P-A. Soluble IL-6 receptor strongly increases the production of acute-phase protein by hepatoma cells but exerts minimal changes on human primary hepatocytes. Eur J Immunol 1995; 25: 2378-2383.
71. De Benedetti F, Massa M, Pignatti P, Albani S, Novick D, Martini A. Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis. J Clin Invest 1994; 93: 2114-2119.
72. Geisterfer M, Richards C, Baumann M, Fey G, Gywnne D, Gauldie J. Regulation of IL-6 and the hepatic IL-6 receptor in acute inflammation in vivo. Cytokine 1993; 5: 1-7.
73. Geisterfer M, Richards CD, Gauldie J. Cytokines oncostatin M and IL-1 regulate the expression of the IL-6 receptor (gp80, gp130). Cytokine 1995; 7: 503-509.
74. Schooltink H, Schmitz-Van de Leur H, Heinrich PC, Rose John S. Up-regulation of the IL-6-signal transducing protein (gp130) by IL-6 and dexamethasone in HepG2 cells. FEBS Lett 1992; 297: 263-265.
75. Moshage H, Yap SH. Molecular and cellular biology of the liver. Curr Opinion Gastroenterol 1993; 9: 367-373.
76. Takehara T, Matsumoto K, Nakamura T. Cell density-dependent regulation of albumin synthesis and DNA synthesis in rat hepatocytes by hepatocyte growth factor. J Biochem 1992; 112: 330-334.
77. Koj A, Guzdek A, Nakamura T, Kordula T. Hepatocyte growth factor and retinoic acid exert opposite effects on synthesis of type 1 and type 2 acute phase proteins in rat hepatoma cells. Int J Biochem Cell Biol 1995; 27: 39-46.
78. Guillen MI, Gomez-Lechon MJ, Nakamura T, Castell JV. The hepatocyte growth factor regulates the synthesis of acute phase proteins in human hepatocytes: divergent effect on IL-6-stimulated genes. Hepatology 1996; 23: 1345-1352.
79. Busso N, Chesne C, Delers F, Morel F, Guillouzo A. TGF-β inhibits albumin synthesis in normal human hepatocytes and in hepatoma HepG2 cells. Biochem Biophys Res Commun 1990; 171: 647-654.
80. Hassan JH, Chelucci C, Peschle C, Sorrentino V. Transforming growth factor-β (TGF-β) inhibits expression of fibrinogen and Factor VII in a hepatoma cell line. Thrombosis Haemostasis 1992; 67: 478-483.
81. Mackiewicz A, Ganapathi MK, Schultz D, et al. Transforming growth factor β1 regulates production of acute phase proteins. Proc Natl Acad Sci USA 1990; 87: 1491-1495.
82. Morrone G, Cortese R, Sorrentino V. Post-transcriptional control of negative acute phase genes by transforming growth factor beta. EMBO J 1989; 8: 3767-3771.
83. Morrone G, Poli V, Hassan JH, Sorrentino V, Effects of TGF-β on liver genes expression. FEBS Lett 1992; 301: 1-4.
84. Campos SP, Baumann H. Insulin is a prominent modulator of the cytokine-stimulated expression of acute-phase plasma protein genes. Mol Cell Biol 1992; 12: 1789-1797.
85. O'Riordain MG, Ross JA, Fearon KCH, et al. Insulin and counterregulatory hormones influence acute-phase protein production in human hepatocytes. Am J Physiol 1995; 269: E323-E330.
86. Thompson D, Harrison SP, Evans SW, Whicher JT. Insulin modulation of acute phase protein production in a human hepatoma cell line. Cytokine 1991; 3: 619-626.
87. Campos SP, Wang Y, Koj A, Baumann H. Insulin cooperates with IL-1 in regulating expression of α1-acid glycoprotein gene in rat hepatoma cells. Cytokine 1994; 6: 485-492.
88. Milland J, Tsykin A, Thomas T, Aldred AR, Cole T, Schreiber G. Gene expression in regenerating and acute-phase rat liver. Am J Physiol 1990; 259: G340-G347.
89. Princen HMG, Selten GCM, Selten-Versteegen AME, Mol-Backx GPBM, Nieuwenhuizen W, Yap SH. Distribution of mRNAs of fibrinogen polypeptides and albumin in free and membrane-bound polyribosomes and induction of α-fetoprotein mRNA synthesis during liver regeneration after partial hepatectomy. Biochim Biophys Acta 1982; 699: 121-130.
90. Fausto N, Webber EM. Liver regeneration. In: Arias IM, Boyer JL, Fausto N, Jakoby WB, Schachter DA, Shafritz DA, eds. The Liver, Biology and Pathobiology. New York: Raven Press, 1994; 1059-1084.
91. Diehl AM, Rai RM. Regulation of signal transduction during liver regeneration. FASEB J 1996; 10: 215-227.
92. Akerman P, Cote P, Yang SQ, et al. Antibodies to tumor necrosis factor-α inhibit liver regeneration after partial hepatectomy. Am J Physiol 1992; 263: G579-G585.
93. Goss JA, Mangino MJ, Callery MP, Flye MW. Prostaglandin E2 down-regulates Kupffer cell production of IL-1 and IL-6 during regeneration. Am J Physiol 1993; 264: G601-G608.
94. Rai RM, Yang SQ, McClain C, Karp CL, Klein AS, Diehl AM. Kupffer cell depletion by gadolinium chloride enhances liver regeneration after partial hepatectomy in rats. Am J Physiol 1996; 270: G909-G918.
95. Cressman DE, Greenbaum LE, Haber BA, Taub R. Rapid activation of post-hepatectomy factor/nuclear factor κB in hepatocytes, a primary response in the regenerating liver. J Biol Chem 1994; 269: 30429-30435.
96. Taub R. Transcriptional control of liver regeneration. FASEB J 1996; 10: 413-427.
97. Diehl AM, Yin M, Fleckenstein J, et al. Tumor necrosis factor-α induces c-jun during the regenerative response to liver injury. Am J Physiol 1994; 267: G552-G561.
98. Cornell RP, Liljequist BL, Bartizal KF. Depressed liver regeneration after partial hepatectomy of germ-free, athymic and lipopolysaccharide-resistant mice. Hepatology 1990; 11: 916-922.
99. Rai R, Karp C, Loffreda S, Yang SQ, Diehl AM. Increased expression of the hepatocyte growth factor (HGF) gene is associated with enhanced liver regeneration after partial hepatectomy (PH) in Kupffer cell-depleted rats. Gastroenterology 1996; 106 (Suppl): A1301.
100. Boulton R, Calnan D, Selden C, Hodgson H. Enhanced sensitivity to growth factor inhibition by IL-1 in regenerating hepatocytes and bi-phasic expression of IL-1 mRNA in regenerating liver implicate IL-1 in the control of liver regeneration, Gastroenterology 1996; 106 (Suppl): A1155.
101. Boulton R, Calnan D, Selden C, Hodgson H. IL-1α and IL-1β generated from non-parenchymal cells after partial hepatectomy are major contributors to the termination of the hepatocyte DNA synthetic phase of hepatic regeneration. Gastroenterology 1995; 108 (Suppl): A1038.
102. Burt AD. Cellular and molecular aspects of hepatic fibrosis. J Pathol 1993; 170: 105-114.
103. Pinzani M. Hepatic stellate (Ito) cells: expanding roles for a liver-specific pericyte. J Hepatol 1995; 22: 700-706.
104. Pinzani M, Milani S, Herbst H, et al. Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis. Am J Pathol 1996; 148: 785-800.
105. 4-exposed rat fat-storing cells and facilitates activation of latent TGF-β in cocultures with sinusoidal endothelial cells. Hepatology 1995; 21: 1429-1437.
106. Lund LR, Riccio A, Andreasen PA. et al. Transforming growth factor-β is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts. EMBO J 1987; 6: 1281-1286.
107. Rieder H, Armbrust T, Meyer zum Büschenfelde KH, Ramadori G. Contribution of sinusoidal endothelial liver cells to liver fibrosis. Expression of transforming growth factor-β1 receptors and modulation of plasmingenerating enzymes by transforming growth factor-β1. Hepatology 1993; 18: 937-944.
108. Iredale JP. Matrix turnover in fibrogenesis. Hepato-Gastroenterology 1996; 43: 56-71.
109. Travis J, Salvesen GS. Human plasma proteinase inhibitors. Annu Rev Biochem 1983; 52: 655-709.
110. Bachem MG, Burschel G, Boers W, et al. Feed back regulation between α2-macroglobulin and TGF-β1. Its putative role in liver fibrogenesis. In: Knook DL, Wisse E, eds. Cells of the Hepatic Sinusoid, Vol. 4. Rijswijk: Kupffer Cell Foundation, 1993; 218-221.
111. Bonner JC. Regulation of platelet-derived growth factor (PDGF) and alveolar macrophage-derived PDGF by α2-macroglobulin. Ann NY Acad Sci 1994; 737: 324-338.
112. LaMarre J, Wollenberg GK, Gonias SL, Hayes MA. Cytokine binding and clearance properties of proteinase-activated α2-macroglobulins. Lab Invest 1991; 65: 3-14.
113. Tiggelman AMBC, Boers W, Linthorst C, Brand HS, Sala M, Chamuleau RAFM. Interleukin-6 production by human liver (myo)fibroblasts in culture: evidence for a regulatory role of LPS, IL-1β and TNFα. J Hepatol 1995; 23: 295-306.
114. Tiggelman AMBC, Boers W, Moorman AFM, et al. Localisation of α2-macroglobulin protein and mRNA in rat liver fibrosis. Evidence for the synthesis of α2-macroglobulin within Schistosoma mansoni egg-granulomas. Hepatology 1996; 23: 1260-1267.